Trial intelligence / Profile preview

Bronchoscopic indocyanine green fluorescence imaging for the evaluation of anastomotic healing after lung transplantation

2016-000888-16Phase 2Completed

Sponsor
Medical University of Vienna
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of indocyanine green in anastomotic complication, sponsored by Medical University of Vienna. Primary endpoint: Measurable indocyanine green fluorescence at the anastomotic site intra-operative. Started Apr 2018; status: completed.

02

Drugs

indocyanine green
03

Conditions

anastomotic complication

Beyond the preview

Go deeper on 2016-000888-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000888-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call